Fourth Dose of BNT162b2 Offers Protection Against Severe COVID-19
FRIDAY, April 8, 2022 (HealthDay News) -- The rates of confirmed severe acute respiratory syndrome coronavirus 2 infection and severe COVID-19 were lower after receipt of a fourth dose of BNT162b2 vaccine, according to a study published online April 5 in the New England Journal of Medicine.
Yinon M. Bar-On, from the Weizmann Institute of Science in Rehovot, Israel, and colleagues extracted data on 1,252,331 persons aged 60 years and older and eligible for the fourth dose during a period of omicron predominance. The rate of confirmed infection and severe COVID-19 was estimated as a function of time starting at eight days after receipt of the fourth dose compared to those who had received only three doses and those who had received a fourth dose three to seven days earlier (four-dose group, three-dose group, and internal control group, respectively).
The researchers found that the number of cases of severe COVID-19 per 100,000 person-days was 1.5, 3.9, and 4.2 in the aggregated four-dose group, the three-dose group, and the internal control group, respectively. The adjusted rate of severe COVID-19 in the fourth week after receipt of the fourth dose was 3.5-fold and 2.3-fold lower than in the three-dose group and the internal control group, respectively. During the six weeks after receipt of the fourth dose, protection against severe illness did not wane. The adjusted rate of confirmed infection in the fourth week was 2.0-fold and 1.8-fold lower after receipt of the fourth dose than in the three-dose and internal control groups, respectively; this protection waned in later weeks.
"A fourth dose appeared to increase the protection against severe illness relative to three doses that were administered more than four months earlier," the authors write.
Related Posts
Hormone Replacement Therapy May Raise a Woman’s Risk for Chronic Reflux
MONDAY, July 3, 2023 (HealthDay News) -- Some women take hormone replacement...
Shift Work Tied to Higher Risk for Reflux Esophagitis
MONDAY, March 6, 2023 (HealthDay News) -- Shift work was significantly...
Adultos con TDAH podrían enfrentar un mayor riesgo de demencia
MIÉRCOLES, 18 de octubre de 2023 (HealthDay News) - Los adultos con trastorno...
Risk of Suicidal Thoughts With Popular Weight-Loss Drugs Being Investigated by European Regulators
TUESDAY, July 11, 2023 (HealthDay News) -- The European Medicines Agency is...